Your browser doesn't support javascript.
loading
Fusidic acid targets elongation factor G in several stages of translocation on the bacterial ribosome.
Borg, Anneli; Holm, Mikael; Shiroyama, Ikue; Hauryliuk, Vasili; Pavlov, Michael; Sanyal, Suparna; Ehrenberg, Måns.
Afiliação
  • Borg A; From the Department of Cell and Molecular Biology, Biomedical Center, Uppsala University, Box 596, 751 24 Uppsala, Sweden and 3H Biomedical AB, Dag Hammarskjölds Väg 34A, Uppsala Science Park, 751 83 Uppsala, Sweden.
  • Holm M; From the Department of Cell and Molecular Biology, Biomedical Center, Uppsala University, Box 596, 751 24 Uppsala, Sweden and.
  • Shiroyama I; From the Department of Cell and Molecular Biology, Biomedical Center, Uppsala University, Box 596, 751 24 Uppsala, Sweden and.
  • Hauryliuk V; From the Department of Cell and Molecular Biology, Biomedical Center, Uppsala University, Box 596, 751 24 Uppsala, Sweden and.
  • Pavlov M; From the Department of Cell and Molecular Biology, Biomedical Center, Uppsala University, Box 596, 751 24 Uppsala, Sweden and.
  • Sanyal S; From the Department of Cell and Molecular Biology, Biomedical Center, Uppsala University, Box 596, 751 24 Uppsala, Sweden and.
  • Ehrenberg M; From the Department of Cell and Molecular Biology, Biomedical Center, Uppsala University, Box 596, 751 24 Uppsala, Sweden and ehrenberg@xray.bmc.uu.se.
J Biol Chem ; 290(6): 3440-54, 2015 Feb 06.
Article em En | MEDLINE | ID: mdl-25451927
The antibiotic fusidic acid (FA) targets elongation factor G (EF-G) and inhibits ribosomal peptide elongation and ribosome recycling, but deeper mechanistic aspects of FA action have remained unknown. Using quench flow and stopped flow experiments in a biochemical system for protein synthesis and taking advantage of separate time scales for inhibited (10 s) and uninhibited (100 ms) elongation cycles, a detailed kinetic model of FA action was obtained. FA targets EF-G at an early stage in the translocation process (I), which proceeds unhindered by the presence of the drug to a later stage (II), where the ribosome stalls. Stalling may also occur at a third stage of translocation (III), just before release of EF-G from the post-translocation ribosome. We show that FA is a strong elongation inhibitor (K50% ≈ 1 µm), discuss the identity of the FA targeted states, and place existing cryo-EM and crystal structures in their functional context.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Síntese de Proteínas / Fator G para Elongação de Peptídeos / Ácido Fusídico / Antibacterianos Tipo de estudo: Prognostic_studies Idioma: En Revista: J Biol Chem Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suécia País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Síntese de Proteínas / Fator G para Elongação de Peptídeos / Ácido Fusídico / Antibacterianos Tipo de estudo: Prognostic_studies Idioma: En Revista: J Biol Chem Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suécia País de publicação: Estados Unidos